Sector
Subsector
Type of entity
3. Banking
— Credit institutions referred to in
point (1) of Article 4 of
Regulation (EU) No 575/2013(57)
4. Financial market
— Operators of trading venues
infrastructures
referred to in point (24) of Article
4 of Directive 2014/65/EU(58)
— Central counterparties (CCPs)
referred to in point (1) of Article
2 of Regulation (EU) No
648/2012(59)
5. Health
— Healthcare providers referred to
in point (g) of Article 3 of
Directive 2011/24/EU(60)
— EU reference laboratories referred
to in Article 15 of Regulation
XXXX/XXXX on serious crossborder threats to health61
57
58
59
60
61
Regulation (EU) No 575/2013 of the European Parliament and of the Council of 26 June
2013 on prudential requirements for credit institutions and investment firms and amending
Regulation (EU) No 648/2012 (OJ L 176, 27.6.2013, p. 1).
Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on
markets in financial instruments and amending Directive 2002/92/EC and Directive
2011/61/EU (OJ L 173, 12.6.2014, p. 349).
Regulation (EU) No 648/2012 of the European Parliament and of the Council of 4 July 2012
on OTC derivatives, central counterparties and trade repositories (OJ L 201, 27.7.2012, p.
1).
Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on
the application of patients' rights in cross–border healthcare (OJ L 88, 4.4.2011, p. 45).
[Regulation of the European Parliament and of the Council on serious cross-border threats to
health and repealing Decision No 1082/2013/EU, reference to be updated once the proposal
COM (2020)727 final is adopted]
10193/22
ANNEXE
EB/ip, pf
JAI.2
LIMITE
162
FR/EN
Select target paragraph3
Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents